Summary of Medexpress news - December 16, 2022

On Wednesday, December 14, the first reading of the act on clinical trials of medicinal products for human use took place in the Sejm. The statements of the representatives of the parliamentary clubs at the Sejm rostrum showed that the deputies unanimously considered this project to be expected and necessary, both from the perspective of clinical trial participants and the clinical trials market. The deputies emphasized the pro-patient nature of the solutions contained in the draft act, which ensure an even higher level of protection for patients and enable more efficient compensation of possible adverse effects. According to the deputies, the bill provides patients with a protective umbrella by introducing the Clinical Trials Compensation Fund.

{postbox: 86016}

Each year, nearly 50,000 Polish women and men die prematurely due to poor air quality. Winter, due to the energy crisis and the lack of good quality fuel, deepens this impasse. - The Polish health service is prepared to treat severe cases. However, it is not ready to diagnose diseases related to poor air quality early enough - says Dr. Piotr Dąbrowiecki, an allergist from the Department of Infectious Diseases and Allergology of the Military Institute of Medicine, chairman of the Polish Federation of Asthma, Allergy and COPD Patients' Associations. The interview can be read on Medexpress.pl

{postbox: 86015}

Announcement on the minimum number of training places for nurses and midwives, the maximum amount of co-financing for one training place and the maximum amount for specialization training in 2023 was published in the Journal of Laws of the Ministry of Health.

According to the announcement, the minimum number of training places for nurses and midwives starting specialization in 2023 is 2,525. The maximum amount of co-financing for one training place for specialization starting in 2023 is PLN 3,950. In turn, the maximum amount allocated for specialization training next year is PLN 10,000,000.

{postbox: 86012}

– In women with selenium deficiency, which in Poland constitute one third of the general female population, supplementation of this element allows to reduce mortality ten times, regardless of the cause, said in an interview for TVP3 Szczecin, prof. Jan Lubiński, head of the Department of Genetics and Pathomorphology of the Medical University of Szczecin and the International Center for Hereditary Cancer, summarizing the results of research conducted at the university for three years. Studies have shown the importance of selenium in the prevention and support of the treatment of breast cancer.

{postbox: 86018}